Dr. Eskandanian, chief innovation officer at Children’s National, has transformed pediatric innovation by establishing an infrastructure supporting internal and external innovators. Under her leadership, Children’s National secured a 10-year, $15 million Biomedical Advanced Research and Development Authority contract with a $515 million ceiling, as well as a $7.5 million FDA grant to lead the Alliance for Pediatric Device Innovation for the third consecutive time. She spearheaded the launch of the pediatric technology and device translation center, leveraging $300,000 in FDA funding to facilitate clinical trials and AI-driven research. Dr. Eskandanian also developed partnerships with organizations such as OrthoPediatrics and CobiCure, the latter funding a $780,000 MedTech innovation fellowship. She organizes flagship events like the annual symposium on pediatric device innovation and “innovation day”, which encourages investors, clinicians and regulators to collaborate to advance pediatric solutions. Dr. Eskandanian is also a 2024 Washington Business Journal healthcare innovation leader honoree.
